FDA Guidance for Industry: Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act

Title:
FDA Guidance for Industry: Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act
Origin/Publisher:

FDA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM377051.pdf

Content:
This guidance is intended for facilities planning to register or renew registration as human drug compounding outsourcing facilities (outsourcing facilities).

Go back